Fresenius Medical Care AG
About Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2013
- $5.0B
- Net income
- $1.1B
- Total assets
- $26.9B
- Market cap
- $11.8B
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $11.8B
- Dividend yield
- 3.97%
- Shares outstanding
- 543.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 17, 1996
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $1.1B in FY2013.
- Trading 27% below its 52-week high.
- Pays a dividend yielding about 3.97% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Fresenius Medical Care AG.
Write a review
News about Fresenius Medical Care AG
News & sentiment via Polygon.io
